Fischer Frank M 4

What Happened
Frank M. Fischer, a director of NeuroPace, was granted two awards on 2026-06-05: 2,890 shares (direct award) and 5,368 derivative shares (award/option). Both grants show an acquisition price of $0.00 on the Form 4, so the reported cash value at grant is $0; together they represent 8,258 underlying shares awarded to Fischer. These are grants (code A), not open-market purchases or sales.

Key Details

• Transaction date: 2026-06-05 (report filed 2026-06-05; accession 0001297260-26-000005).
• Grants: 2,890 shares @ $0.00 (direct award); 5,368 derivative shares @ $0.00 (award/option). Combined = 8,258 shares.
• Vesting: Both awards vest in twelve (12) equal consecutive monthly installments, subject to Fischer’s continuous service through each vesting date (Footnotes F1 and F2).
• Shares owned after transaction: Not specified on the information provided in this summary (not disclosed in the details supplied).
• No 10b5-1 plan, tax withholding, or late-filing indication noted in the provided filing.

Context
These are standard equity awards to a director and are reported as grants rather than purchases or sales. The derivative grant means Fischer will receive or be able to acquire the underlying shares as they vest (per the 12-month monthly schedule); this is not an immediate cash sale or exercise. Such grants compensate service and align management with shareholders but do not alone indicate a buy/sell signal.